Allogene Therapeutics Inc (ALLO)

Finanzdaten der Allogene Therapeutics Inc-Aktie (ALLO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4.64	-	-	-	-
	11.86%51.56	46.09	42.40	44.90	56.82
Research and Development	4.01%30.72	32.00	28.63	31.16	40.16
Operating Income/Loss	1.80%-46.92	-46.09	-42.40	-44.90	-56.82
Nonoperating Income/Loss	21.75%4.24	3.49	3.59	3.50	5.88
	0.16%-42.68	-42.61	-38.81	-41.40	-50.94
Attributable To Parent	0.16%-42.68	-42.61	-38.81	-41.40	-50.94
Basic Average Shares	36.89%328.93	240.29	-	222.04	218.93
Diluted Average Shares	36.89%328.93	240.29	-	222.04	218.93
Basic Earnings Per Share	27.78%-0.13	-0.18	-	-0.19	-0.23
Diluted Earnings Per Share	27.78%-0.13	-0.18	-	-0.19	-0.23